$0.94
Value $20M
PETS and PM stock compared: price, dividend, valuation and results, from SEC filings.
$0.94
Value $20M
$198.96
Value $310B
PetMed Express (PETS) has a market value of $20M and Philip Morris International (PM) $310B. Over the last year, with dividends, PETS moved -67.6% and PM +32.4%. Dividend yield: PETS none, PM 3.02%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
PETS$20M
PM$310B
PM is 15,418 times PETS
Revenue, 12 months
PETS$160M
PM$43.1B
PM is 269 times PETS
Net income, 12 months
PETS-$27M
PM$10.7B
Operating margin
PETS-18.0%
PM38.6%
56.6 points apart
ROIC
PETS-78.7%
PM34.6%
113.3 points apart
P/E
PETS–
PM29.0
Dividend yield
PETS0.0%
PM3.0%
3.0 points apart
5-year return
PETS-96.5%
PM+164.5%
261.0 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
PETS-96.5%
PM+164.5%
| Period | PETSWith dividends | PMWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | -67.6%Price -67.6% | +32.4%Price +27.9% |
| 3 years since November 13, 2023 | -87.4%-49.8% a yearPrice -87.4% | +150.1%+35.7% a yearPrice +121.1% |
| 5 years since November 12, 2021 | -96.5%-48.7% a yearPrice -96.8% | +164.5%+21.5% a yearPrice +110.0% |
| 10 years since November 15, 2016 | -94.2%-24.8% a yearPrice -95.7% | +273.2%+14.1% a yearPrice +127.4% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
PETSPetMed ExpressPMPhilip Morris International
| Price | $0.94 | $198.96 |
|---|---|---|
| Market value | $20M | $310B |
| Enterprise value (EV) | $8.7M | $351B |
| P/E | – | 29.0 |
| P/E, 5-year median | – | 18.7 |
| P/B | 1.2 | – |
| EV/EBIT | – | 21.0 |
| Free cash flow yield | – | 4.4% |
| Revenue, 12 months | $160M | $43.1B |
|---|---|---|
| Net income, 12 months | -$27M | $10.7B |
| Free cash flow, 12 months | -$25M | $13.6B |
| Earnings per share, 12 months | -$1.28 | $6.85 |
| Revenue growth, year on year | -21.1% | 7.3% |
| Revenue growth a year, past | -10.0%over 5 years | +7.2%over 5 years |
| EPS growth a year, past | – | +7.1%over 5 years |
| Gross margin | 27.8% | 67.7% |
|---|---|---|
| Operating margin | -18.0% | 38.6% |
| Net margin | -17.0% | 24.8% |
| ROIC | -78.7% | 34.6% |
| ROE | -94.0% | – |
| Cash | $11M | $6.7B |
|---|---|---|
| Total debt | $291.0K | $47.6B |
| Net debt / EBITDA | – | 2.2 |
| Interest cover | – | 10.5× |
| Dividend yield | – | 3.0% |
|---|---|---|
| Dividend per share, 12 months | – | $6.01 |
| Dividend growth a year, past | – | +3.5%over 5 years |
| Buyback yield | – | – |
| Shareholder yield | – | 3.0% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Philip Morris International ($310B) is about 15,417.9 times PetMed Express ($20M), at today's prices.
Since November 15, 2016, PETS's price moved -95.7% and PM's +127.4%. With dividends: PETS -94.2% (-24.8% a year), PM +273.2% (+14.1% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for PetMed Express and 3.02% for Philip Morris International. Over the last twelve months they paid – and $6.01 per share.
Over the last twelve months, the net margin was -17.0% for PetMed Express and 24.8% for Philip Morris International, and the operating margin -18.0% and 38.6%. Revenue was $160M and $43.1B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.